Erica Vetrano

2.2k total citations · 3 hit papers
34 papers, 1.3k citations indexed

About

Erica Vetrano is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Erica Vetrano has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 14 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Molecular Biology. Recurrent topics in Erica Vetrano's work include Diabetes Treatment and Management (10 papers), Cardiovascular Function and Risk Factors (9 papers) and Metabolism, Diabetes, and Cancer (8 papers). Erica Vetrano is often cited by papers focused on Diabetes Treatment and Management (10 papers), Cardiovascular Function and Risk Factors (9 papers) and Metabolism, Diabetes, and Cancer (8 papers). Erica Vetrano collaborates with scholars based in Italy, United States and United Kingdom. Erica Vetrano's co-authors include Luca Rinaldi, Raffaele Galiero, Alfredo Caturano, Ferdinando Carlo Sasso, Teresa Salvatore, Raffaele Marfella, Celestino Sardu, Gaetana Albanese, Anna Di Martino and Pia Clara Pafundi and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Antioxidants.

In The Last Decade

Erica Vetrano

31 papers receiving 1.3k citations

Hit Papers

Oxidative Stress in Type ... 2023 2026 2024 2023 2023 2025 50 100 150 200 250

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Erica Vetrano 532 394 348 277 253 34 1.3k
Alfredo Caturano 867 1.6× 549 1.4× 490 1.4× 523 1.9× 366 1.4× 74 2.1k
Luping Guo 245 0.5× 541 1.4× 288 0.8× 464 1.7× 266 1.1× 26 1.7k
Guijun Qin 417 0.8× 553 1.4× 175 0.5× 426 1.5× 220 0.9× 88 1.7k
Raffaele Galiero 995 1.9× 612 1.6× 509 1.5× 630 2.3× 420 1.7× 58 2.3k
Tetsuro Miyazaki 301 0.6× 267 0.7× 526 1.5× 338 1.2× 283 1.1× 95 1.5k
Yunfeng Shen 387 0.7× 520 1.3× 188 0.5× 312 1.1× 202 0.8× 46 1.3k
Mohamed A. Haidara 180 0.3× 347 0.9× 134 0.4× 218 0.8× 189 0.7× 88 1.4k
William G. McMaster 239 0.4× 337 0.9× 374 1.1× 144 0.5× 312 1.2× 20 1.5k
Evelina Maria Gosav 283 0.5× 408 1.0× 144 0.4× 398 1.4× 95 0.4× 23 1.1k
Konstantinos Paletas 311 0.6× 300 0.8× 109 0.3× 494 1.8× 168 0.7× 35 1.2k

Countries citing papers authored by Erica Vetrano

Since Specialization
Citations

This map shows the geographic impact of Erica Vetrano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erica Vetrano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erica Vetrano more than expected).

Fields of papers citing papers by Erica Vetrano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erica Vetrano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erica Vetrano. The network helps show where Erica Vetrano may publish in the future.

Co-authorship network of co-authors of Erica Vetrano

This figure shows the co-authorship network connecting the top 25 collaborators of Erica Vetrano. A scholar is included among the top collaborators of Erica Vetrano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erica Vetrano. Erica Vetrano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caturano, Alfredo, Maria Rocco, Giovanni Di Lorenzo, et al.. (2025). Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications. Antioxidants. 14(1). 72–72. 40 indexed citations breakdown →
2.
Caturano, Alfredo, Giovanni Di Lorenzo, Maria Rocco, et al.. (2025). Cardiovascular Health in the Shadow of Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease: An Emerging Paradigm. Reviews in Cardiovascular Medicine. 26(11). 43143–43143.
3.
Vetrano, Erica, Raffaele Galiero, Vittorio Simeon, et al.. (2025). Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study. Pharmaceuticals. 18(8). 1200–1200.
4.
Caturano, Alfredo, Erica Vetrano, Raffaele Galiero, et al.. (2024). Advances in the Insulin–Heart Axis: Current Therapies and Future Directions. International Journal of Molecular Sciences. 25(18). 10173–10173. 7 indexed citations
5.
Caturano, Alfredo, Raffaele Galiero, Erica Vetrano, et al.. (2024). Insulin–Heart Axis: Bridging Physiology to Insulin Resistance. International Journal of Molecular Sciences. 25(15). 8369–8369. 19 indexed citations
6.
Caturano, Alfredo, Raffaele Galiero, Maria Rocco, et al.. (2024). The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease. Biomolecules. 14(11). 1393–1393. 6 indexed citations
7.
Caturano, Alfredo, Raffaele Galiero, Maria Rocco, et al.. (2024). Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care. Biomedicines. 12(9). 2039–2039. 8 indexed citations
8.
Caturano, Alfredo, Raffaele Galiero, Giuseppe Loffredo, et al.. (2023). Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study. Biomedicines. 11(2). 322–322. 30 indexed citations
9.
Cesaro, Arturo, Erica Vetrano, Giovanni Signore, et al.. (2023). Sodium–Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice. International Journal of Molecular Sciences. 24(9). 8099–8099. 8 indexed citations
10.
Vetrano, Erica, Luca Rinaldi, Andrea Mormone, et al.. (2023). Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies. Biomedicines. 11(2). 468–468. 58 indexed citations
11.
Caturano, Alfredo, Andrea Mormone, Vincenzo Russo, et al.. (2023). Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications. Current Issues in Molecular Biology. 45(8). 6651–6666. 270 indexed citations breakdown →
12.
Galiero, Raffaele, Alfredo Caturano, Erica Vetrano, et al.. (2023). Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options. International Journal of Molecular Sciences. 24(4). 3554–3554. 89 indexed citations breakdown →
13.
Palmiero, Giuseppe, Arturo Cesaro, Raffaele Galiero, et al.. (2023). Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study. Diabetes Research and Clinical Practice. 200. 110686–110686. 18 indexed citations
14.
Galiero, Raffaele, Alfredo Caturano, Erica Vetrano, et al.. (2023). Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations. Diabetes Metabolic Syndrome and Obesity. Volume 16. 3669–3689. 15 indexed citations
15.
Palmiero, Giuseppe, Emanuele Monda, Marta Rubino, et al.. (2022). Modified Body Mass Index as a Novel Nutritional and Prognostic Marker in Patients with Cardiac Amyloidosis. SHILAP Revista de lepidopterología. 12(2). 185–197. 1 indexed citations
16.
Salvatore, Teresa, Raffaele Galiero, Alfredo Caturano, et al.. (2022). Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes. International Journal of Molecular Sciences. 24(1). 658–658. 26 indexed citations
17.
Palmiero, Giuseppe, Arturo Cesaro, Erica Vetrano, et al.. (2021). Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects. International Journal of Molecular Sciences. 22(11). 5863–5863. 71 indexed citations
18.
Sasso, Ferdinando Carlo, Pia Clara Pafundi, Alfredo Caturano, et al.. (2021). Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes. Nutrition Metabolism and Cardiovascular Diseases. 31(8). 2345–2353. 44 indexed citations
19.
Palmiero, Giuseppe, Erica Vetrano, Marta Rubino, et al.. (2021). The Role of New Imaging Technologies in the Diagnosis of Cardiac Amyloidosis. Heart Failure Clinics. 18(1). 61–72. 10 indexed citations
20.
Lioncino, Michele, Emanuele Monda, Giuseppe Palmiero, et al.. (2021). Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis. Heart Failure Clinics. 18(1). 73–87. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026